共 50 条
- [41] A RANDOMIZED, DOUBLE-BLIND TRIAL OF FLUOROURACIL PLUS PLACEBO VERSUS FLUOROURACIL PLUS ORAL LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL-CANCERJOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1888 - 1893LAUFMAN, LRBUKOWSKI, RMCOLLIER, MASULLIVAN, BAMCKINNIS, RACLENDENNIN, NJGUASPARI, ABRENCKMAN, WD
- [42] Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation studyJOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10Hou, JianJin, JieXu, YanWu, DepeiKe, XiaoyanZhou, DaobinLu, JinDu, XinChen, XiequnLi, JunminLiu, JingGupta, NeerajHanley, Michael J.Li, HongmeiHua, ZhaoweiWang, BingxiaZhang, XiaoquanWang, Huivan de Velde, HelgiRichardson, Paul G.Moreau, Philippe
- [43] Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation studyJournal of Hematology & Oncology, 10Jian HouJie JinYan XuDepei WuXiaoyan KeDaobin ZhouJin LuXin DuXiequn ChenJunmin LiJing LiuNeeraj GuptaMichael J. HanleyHongmei LiZhaowei HuaBingxia WangXiaoquan ZhangHui WangHelgi van de VeldePaul G. RichardsonPhilippe Moreau
- [44] Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Placebo-Controlled Phase III StudyONCOLOGIST, 2013, 18 (03): : 257 - 264Swain, Sandra M.Ewer, Michael S.Cortes, JavierAmadori, DinoMiles, DavidKnott, AdamClark, EmmaBenyunes, Mark C.Ross, GrahamBaselga, Jose
- [45] A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGBJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Kindler, H. L.Niedzwiecki, D.Hollis, D.Oraefo, E.Schrag, D.Hurwitz, H.McLeod, H. L.Mulcahy, M. F.Schilsky, R. L.Goldberg, R. M.
- [46] Rationale and Design for the LUME-Colon 1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Nintedanib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Colorectal Cancer Refractory to Standard TreatmentCLINICAL COLORECTAL CANCER, 2016, 15 (01) : 91 - 94Van Cutsem, EricYoshino, TakayukiHocke, JuliaOum'Hamed, ZohraStudeny, MatusTabernero, Josep
- [47] A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancerBRITISH JOURNAL OF CANCER, 2015, 113 (10) : 1421 - 1426Lim, S. H.Kim, T. W.Hong, Y. S.Han, S-WLee, K-HKang, H. J.Hwang, I. G.Lee, J. Y.Kim, H. S.Kim, S. T.Lee, J.Park, J. O.Park, S. H.Park, Y. S.Lim, H. Y.Jung, S-HKang, W. K.
- [48] A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancerBritish Journal of Cancer, 2015, 113 : 1421 - 1426S H LimT W KimY S HongS-W HanK-H LeeH J KangI G HwangJ Y LeeH S KimS T KimJ LeeJ O ParkS H ParkY S ParkH Y LimS-H JungW K Kang
- [49] Capecitabine (X) compared to X plus erlotinib (E) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC): Interim efficacy results from a randomized phase II studyJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Vincent, M.Kerr, I.Dingle, B.MacKenzie, M. J.Sanatani, M.
- [50] A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (NCT03748641)ANNALS OF ONCOLOGY, 2019, 30Chi, K. N.Rathkopf, D.Attard, G.Smith, M. R.Efstathiou, E.Olmos, D.Small, E. J.Lee, J. Y.Sieber, P.Dunshee, C.Ricci, D.Simon, J. S.Zhao, X.Kothari, N.Cheng, S.Sandhu, S. K.